CRBP vs OGN · $102.3M cap vs P/E 3.4, rev $3.02B
Corbus Pharmaceuticals Holding (CRBP) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
CRBP does not have a complete income-statement cache yet.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CRBP currently screens at market cap $102.3M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CRBP and OGN stock pages for the full models.
Not investment advice.